Monthly Archives - January 2017

Corbus Pharmaceuticals Receives Orphan Designation for JBT-101 for the Treatment of Systemic Sclerosis in the European Union

Corbus Pharmaceuticals Holdings, Inc. (CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that the European Commission has granted Orphan Designation in the European Union (“EU”) for the Company’s novel synthetic oral endocannabinoid-mimetic drug, JBT-101 (“Resunab”) for the treatment of systemic sclerosis. Read more >>

Why Corbus Pharmaceuticals Holdings, Inc. Stock Rocketed 412% Upwards in 2016

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) thrilled investors with a 412.1% gain last year, according todata from S&P Global Market Intelligence Opens a New Window. . Positive mid-stage clinical trial results for its lead drug, Resunab, lifted the stock and ignited hope for further expansion in the future. Read more >>

LORD Corporation Selects Aras PLM Platform to Standardize Product Development Processes, Manage Growth

Aras®, the next leader in enterprise Product Lifecycle Management (PLM) software, today announced that LORD Corporation, a leading global manufacturer of adhesives, coating, sensing and motion technologies, selected Aras Innovator® to standardize product development processes at current sites, and to help the company efficiently support emerging businesses. Read more >>

Ottobock Signs Distribution Agreement With Myomo

Ottobock, a market leader in technical orthopedics, and Myomo, Inc., a manufacturer of myoelectric orthotics, have reached an agreement for Ottobock to exclusively distribute the Myomo patented MyoPro orthosis technology globally, starting with select markets in North America and Germany. Read more >>

Daktari Announces Formation of Scientific Advisory Board

Daktari Diagnostics, a company focused on making “Anywhere. Care.™” a reality with its portable and ultrasensitive immunoassay-based CarePlatform™, today announced the formation of its Scientific Advisory Board (SAB) comprised of global leaders in the diagnostic and biotechnology industries. The SAB will work closely with Daktari’s management team to advance the development of the Company’s rapid and clinically relevant point-of-care (POC) diagnostic solutions. Read more >>

Guilford teen hopes for high tech way to see the world

A Guilford teen has suffered severe vision loss his entire life but he’s getting closer to being able to see with the help of technology.
Alex Russello, 16, was born with optic atrophy. His mother said his optic nerves didn’t fully develop, so it limits his vision.
His only chance of seeing is having objects a couple of inches from his face. In order to watch TV, he has to pull up a chair in front of it.
eSight glasses give Alex, and […]

Glasses From eSight Help Legally Blind Indianapolis Colts Fan See First Game

Scott Reese is a longtime Indianapolis Colts fan, but he didn’t see the team win Super Bowl XLI or Peyton Manning claim the single-season touchdown record in 2004. Because Reese is legally blind, he wasn’t even able to see the games on TV.
But he was able to watch the action for the first time Sunday at Lucas Oil Stadium thanks to a pair of eSight glasses. The Colts learned about Reese’s story and provided him with sidelines tickets and […]

AL HAMNIK: Shedding light on life’s challenges

Scott Reese had sent a letter to Canadian-based eSight, telling his story of endless challenges and ordeals. To his surprise, the company contacted him weeks later, asking if he would want to participate in a demonstration involving the electronic glasses it manufactures to enhance the vision of those with vision loss. Read more >>